FDA Issues Nationwide Class II Recall for Over 2.5 Million Steroid Eye Drop Bottles
WASHINGTON — Federal regulators recently upgraded the enforcement status of a massive, nationwide medical recall. Specifically, this issue involves millions of prescription steroid eye drop bottles distributed across the United States.
Consequently, the U.S. Food and Drug Administration (FDA) finalized a Class II classification for a voluntary recall. Lupin Pharmaceuticals originally initiated this safety action. According to official reporting by The Hill via Livemint, the recall covers exactly 2,530,182 bottles of medication. Doctors widely prescribe this Prednisolone Acetate Ophthalmic Suspension to treat non-infectious eye allergies and swelling.
Possible Contamination Sparks Action
First and foremost, a single product complaint sparked the federal intervention. This complaint alleged the presence of an unidentified foreign substance inside the medicine batches. However, neither the manufacturer nor the regulatory agency has publicly identified the specific floating material.
Furthermore, a Class II recall status indicates a specific level of danger. Exposure to these contaminated eye drops could potentially cause temporary or medically reversible health issues. Nevertheless, the FDA notes that the overall probability of serious, long-term vision damage remains remote.
Fortunately, no adverse infections or patient illnesses have been officially linked to the affected product lots so far. According to clinical updates from the Ophthalmology Times, labs are still evaluating the returned product samples.
Affected Product Batches and Lot Codes
Currently, the recall includes three distinct retail bottle sizes distributed directly to pharmacies and wholesale warehouses nationwide. Therefore, you should check your packaging for the following National Drug Codes (NDCs):
-
5 mL Bottles: Look for NDC 70748-332-02.
-
10 mL Bottles: Check for NDC 70748-332-03.
-
15 mL Bottles: Identify NDC 70748-332-04.
In addition, the active expiration dates on these flagged packages span from July 31, 2026, through March 31, 2028.
Essential Guidance for Patients
Because Prednisolone is a vital anti-inflammatory steroid, health officials warn patients against stopping their therapy routine abruptly. Instead, you should consult a professional first.
As a result, consumers holding inventory from these batches should immediately contact their pharmacist. They can help you secure a clean generic equivalent. According to safety resources published by Everyday Health, you must replace the drops quickly to protect your vision.
For more updates regarding health product alerts and wellness safety, visit our Health and Wellness Niche.
You can watch this short Eye Medication Recall Summary Video for a visual breakdown of how to check your medication labels and manage prescription changes safely.